CAPN1 Gene

CAPN1 Gene

Introduction

Capn1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>CAPN1</td></tr>
<tr><th>Full Name</th><td>Calpain 1 (μ-calpain)</td></tr>
<tr><th>Chromosomal Location</th><td>11q13.1</td></tr>
<tr><th>NCBI Gene ID</th><td>823</td></tr>
<tr><th>OMIM</th><td>114220</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000021645</td></tr>
<tr><th>UniProt ID</th><td>P07384</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, Stroke, Traumatic Brain Injury, ALS, Huntington's Disease</td></tr>
</table>
</div>

Overview

CAPN1 Gene

Introduction

Capn1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>CAPN1</td></tr>
<tr><th>Full Name</th><td>Calpain 1 (μ-calpain)</td></tr>
<tr><th>Chromosomal Location</th><td>11q13.1</td></tr>
<tr><th>NCBI Gene ID</th><td>823</td></tr>
<tr><th>OMIM</th><td>114220</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000021645</td></tr>
<tr><th>UniProt ID</th><td>P07384</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, Stroke, Traumatic Brain Injury, ALS, Huntington's Disease</td></tr>
</table>
</div>

Overview

CAPN1 (Calpain 1), also known as mu-calpain or calcium-activated neutral protease 1, encodes the catalytic subunit of mu-calpain (micromolar calpain), a calcium-dependent cysteine protease["@goll2003"]. This enzyme is part of the calpain family, which catalyzes limited proteolysis of numerous substrates and plays critical roles in both normal cellular function and pathological processes in neurodegenerative diseases["@sorimachi2011"]. Calpain 1 is unique among calpains in its activation by micromolar calcium concentrations, distinguishing it from m-calpain (CAPN2), which requires millimolar calcium.

Function

Structure and Activation

Calpain 1 is a heterodimer composed of[@hanna2008]:

• Catalytic subunit (CAPN1, 80 kDa): Contains the protease core with conserved cysteine protease domain
• Regulatory subunit (CAPNS1, 28 kDa): Required for enzyme stability, proper folding, and calcium sensitivity

Activation Mechanism

Key Biological Functions

Disease Associations

Alzheimer's Disease

CAPN1 plays a significant role in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis[@liu2021]:

• Amyloid-beta effects: [Aβ](/proteins/amyloid-beta) peptides trigger calcium dysregulation, leading to calpain overactivation
• [Tau](/proteins/tau) cleavage: Calpain cleaves [tau protein](/proteins/tau), generating toxic fragments that promote [tau aggregation](/mechanisms/tau-pathology)
• Caspase activation: Calpain activates [caspase-3](/proteins/caspase-3-protein), linking to apoptotic cell death
• Synaptic damage: Overactivated calpain degrades synaptic proteins including [PSD-95](/proteins/psd95-protein) and [NMDA receptors](/entities/nmda-receptor)
• Biomarkers: Calpain-cleaved spectrin breakdown products (SBDPs) serve as biomarkers of neuronal injury

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease)[@cao2023]:

• [α-Synuclein](/proteins/alpha-synuclein) toxicity: α-Synuclein induces calcium dysregulation in dopaminergic neurons
• Parkin processing: Calpain processes [parkin](/proteins/parkin-protein), affecting [E3 ubiquitin ligase](/mechanisms/ubiquitin-proteasome) function
• Mitochondrial dysfunction: Impaired mitochondria increase intracellular calcium, activating calpain
• [LRRK2](/entities/lrrk2) interactions: [LRRK2](/proteins/lrrk2-protein) mutations may affect calpain-mediated pathways

Stroke and Brain Injury

In acute neurological injury[@vosler2009]:

• Ischemia: Stroke causes massive calcium influx through [NMDA](/entities/nmda-receptor) receptors and voltage-gated channels
• Excitotoxicity: Glutamate-induced calcium overload activates calpain
• Neuroprotection: Calpain inhibitors (E-64d, calpeptin) show neuroprotective effects in stroke models
• Biomarkers: SBDPs are established biomarkers of [traumatic brain injury](/diseases/traumatic-brain-injury)

Amyotrophic Lateral Sclerosis (ALS)

In [ALS](/diseases/amyotrophic-lateral-sclerosis)[@indarto2022]:

• Motor neuron degeneration: Activated calpain in vulnerable motor neurons
• Protein aggregation: Calpain cleaves [TDP-43](/proteins/tdp-43), generating aggregation-prone fragments
• Axonal transport: Calpain impairs axonal transport proteins

Huntington's Disease

In [Huntington's disease](/diseases/huntington-disease)[@zhang2022]:

• Mutant [huntingtin](/proteins/huntingtin-protein): Affects calcium homeostasis, leading to calpain activation
• Transcriptional dysregulation: Calpain cleaves transcriptional regulators
• Dendritic spine loss: Proteolytic activity contributes to synaptic dysfunction

Expression Pattern

Tissue Distribution

Calpain 1 is expressed in most tissues with highest levels in[@murphy1986]:

• Brain: [Neurons](/entities/neurons) and glia
• Skeletal muscle: Post-synaptic membranes
• Liver: Hepatocytes
• Kidney: Tubular cells

Cellular Localization in Brain

• Neurons: Pyramidal cells in [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus)
• Cerebellar Purkinje cells: High expression
• [Astrocytes](/entities/astrocytes): Moderate expression
• [Microglia](/entities/microglia): Activation-dependent expression

Therapeutic Implications

Calpain Inhibitors

Several calpain inhibitors have been investigated[@donkor2019]:

| Compound | Status | Notes |
|----------|--------|-------|
| E-64d | Research | Naturally occurring, [BBB](/entities/blood-brain-barrier) penetration limited |
| Calpeptin | Research | Potent but poor brain penetration |
| MDL-28170 | Preclinical | Shows neuroprotection in stroke models |
| A-705253 | Research | Improved BBB penetration |

Therapeutic Strategies

Challenges

• Achieving brain penetration
• Isoform selectivity (CAPN1 vs. CAPN2)
• Balancing normal calpain function vs. pathological activation
• Timing of intervention in acute injury

Molecular Mechanisms

Substrate Specificity

Calpain cleaves after specific motifs (P-X-P-X-Q):

• Structural proteins: Spectrin, talin, vinculin
• [Tau protein](/proteins/tau): Multiple cleavage sites generating toxic fragments
• Kinases: PKC, CaMKII, MAPK
• Transcription factors: p53, c-Jun, [NF-κB](/entities/nf-kb)
• Apoptotic proteins: Caspase-12, Bid

Signaling Pathways

Calpain participates in multiple cellular pathways:

Ca²⁺ influx → Calpain activation → Substrate cleavage
→ Cytoskeletal remodeling / Signal transduction / Apoptosis

Cross-talk with:

• [Caspase cascade](/mechanisms/apoptosis)
• [MAPK signaling](/mechanisms/mapk-signaling-neurodegeneration)mechanisms/mapk-signaling-neurodegeneration)
• [Oxidative stress](/mechanisms/oxidative-stress) pathways

Animal Models

Knockout Studies

• CAPN1⁻/⁻ mice: Viable but show deficits in long-term memory
• CAPNS1⁻/⁻ mice: Embryonic lethal, demonstrating essential function
• Rescue studies: Neuronal-specific rescue restores viability

Disease Models

• Transgenic AD mice: Calpain activation correlates with Aβ pathology
• Stroke models: Calpain inhibition reduces infarct size
• TBI models: Calpain inhibitors improve functional outcomes

Research Directions

Current research focuses on[@huang2024]:

Key Publications

See Also

• [CAPN2 Gene](/proteins/capn2-protein) - μ-Calpain (m-calpain) catalytic subunit
• [CAPNS1 Gene](/proteins/capns1-protein) - Calpain small subunit
• [Calpastatin](/proteins/calpastatin-protein) - Endogenous calpain inhibitor
• [Excitotoxicity](/mechanisms/excitotoxicity) - Calcium overload mechanism
• [Apoptosis in Neurodegeneration](/mechanisms/apoptosis) - Programmed cell death
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Stroke](/diseases/stroke) - Ischemic brain injury
• [Traumatic Brain Injury](/diseases/traumatic-brain-injury)

External Links

• [NCBI Gene: CAPN1](https://www.ncbi.nlm.nih.gov/gene/823)
• [UniProt: P07384](https://www.uniprot.org/uniprot/P07384)
• [Ensembl: ENSG00000021645](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000021645)
• [GeneCards: CAPN1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CAPN1)
• [OMIM: 114220](https://www.omim.org/entry/114220)

Conclusion

CAPN1 encodes μ-calpain, a calcium-dependent protease critical for cellular signaling and proteolysis. In neurodegenerative diseases, dysregulated calpain activation contributes to protein aggregation, synaptic loss, and neuronal death. While calpain inhibitors have shown promise in preclinical models, achieving brain penetration and isoform selectivity remains challenging. Understanding the precise role of CAPN1 in different disease contexts will be essential for developing effective therapeutic strategies.

Background

The study of Capn1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Pathway Diagram

The following diagram shows the key molecular relationships involving CAPN1 Gene discovered through SciDEX knowledge graph analysis: